c-Myc inhibitor 6
Product Specifications
UNSPSC Description
c-Myc inhibitor 6 (compound A102) is a c-Myc inhibitor. c-Myc inhibitor 6 decreases cancer cell viability and degrades c-Myc protein. c-Myc inhibitor 6 can be used for the research of c-Myc imbalance, such as cancer, cardiovascular diseases, and viral infection[1].
Target Antigen
c-Myc
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/c-myc-inhibitor-6.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C)C[C@@H](B(O)O)NC(CCNC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)=O
Molecular Weight
424.30
References & Citations
[1]Tong, Youzhi, et al. C-myc protein inhibitor, preparation method therefor, and use thereof. WO2022089556. 2021.
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-148836/c-Myc-inhibitor-6-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-148836/c-Myc-inhibitor-6-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2768765-58-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARP48784_P050-HRP 100 µL
LIPT1 Antibody - N-terminal region: HRP (ARP48784_P050-HRP)
Ask
View Details 
